Clinical Trial Update: A Study of the Absorption of GT267-004 in Patients With Clostridium Difficile-Associated Diarrhea [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the absorption of GT267-004 in patients with Clostridioides difficile infection-associated diarrhea has completed, with conditions in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Antibiotic-associated Diarrhea
• Clostridioides Difficile Infection
• Pseudomembranous Colitis

Drugs mentioned

• GT267-004

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Pseudomembranous Colitis, Clostridium Difficile Diarrhea | Phase 2 | Status: COMPLETED